However, a high level of apoA-I110−525 (>19 mg/dl, i.e., higher than the median value) was significantly associated with the presence of any form of coronary atherosclerosis when combined with age and sex [Model 1, OR (95% CI): 3.02 (1.30–7.04); P = 0.01] as well as age, sex, and risk factors for CAD [Model 2, OR (95% CI): 3.89 (1.39–10.9); P = 0.009] in patients not using LLM (Table 3A). This evidence concerns the gene APOA1 and coronary atherosclerosis.